Rinsho Ganka Volume 72, Issue 5 (May 2018)

Intravitreal aflibercept was effective for macular edema in a case of retinal racemose hemangioma with retinal vein occlusion Emi Umetsu 1 , Makiko Matsumoto 1 , Akira Machida 1 , Daisuke Inoue 1 , Eiko Tsuiki 1 , Asuka Ogawa 1 , Takashi Kitaoka 1 1Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences, Nagasaki University pp.671-676
Published Date 2018/5/15
DOI https://doi.org/10.11477/mf.1410212686
  • Abstract
  • Look Inside
  • Reference

Abstract Purpose:To report a case of retinal racemose hemangioma with retinal vein occlusion and macular edema that responded to intravitreal injection of aflibercept.

Case:A 48-year-old male presented with sudden visual loss in the left eye since one week before.

Findings and Clinical Course:Corrected visual acuity was 1.2 in the right eye and 0.1 in the left eye.Both eyes showed vascular malformation with proliferative tissue in the optic disc. The left eye showed brush-like hemorrhage, soft exudates and serous retinal detachment inferior to the disc. Fluorescein angiography showed findings compatible with branch retinal vein occlusion(BRVO). The left eye was treated by intravitreal aflibercept. Macular edema subsided with visual acuity of 0.9 one month later. Visual acuity improved to 1.2 another 2 month later. There has no recurrence for one year until present.

Conclusion:Retinal racemose hemangioma is generally considered as benign without need for treatment. The present case shows that BRVO may develop due to elevated venous pressure and may induce macular edema.

Copyright © 2018, Igaku-Shoin Ltd. All rights reserved.


72巻5号 (2018年5月)
電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院